A Phase I Single Dose, Open Label, Randomized, Three Period Crossover Pilot Study to Compare the Pharmacokinetics, Safety and Tolerability of MVP005 Intranasal Spray With Intranasal Administration of Naloxone Solution for Injection in Healthy Adult Subjects
Latest Information Update: 20 Jan 2020
At a glance
- Drugs Naloxone (Primary)
- Indications Opioid-related disorders
- Focus Pharmacokinetics
Most Recent Events
- 13 Aug 2015 New trial record